A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluationAleix Prat, PierFranco Conte, Tomás Pascual et al.|The Lancet Oncology|2020Cited by 75
97P Genomic bases of endocrine sensitivity in triple-positive early breast cancer: A translational analysis of the PerELISA trialGaia Griguolo, V. Guarneri, Maria Vittoria Dieci et al.|Annals of Oncology|2022Cited by 0